NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Aureate Tradde

Aureate Tradde

IPO
Issue: 27.29 CrPrice: ₹ 70.00
View Details

Aureate Tradde's IPO Sees 50% Subscription on Second Day of Bidding

Aureate Tradde's initial public offer (IPO) has seen a strong response, with over 50% of the shares subscribed on the second day of bidding, which closed on 1 June. The SME IPO will conclude on Tuesday, 2 June.

Founded in 2018, Aureate Tradde is a leading player in the trading, distribution, and supply of industrial and technology-focused materials. The company's business is divided into three key segments: polymers and petrochemicals, lithium-ion and sodium-ion battery cells, and electric vehicle (EV) charging solutions. Its product offerings include PVC and PET resins, polyethylene products, lithium-ion and sodium-ion cells, as well as EV chargers. Aureate Tradde operates on an inventory-led model, maintaining stock in advance to meet the requirements of enterprise customers efficiently.

The company primarily caters to the domestic B2B market for polymers and battery cells, while its EV charging products are sold through both B2B and B2C channels. Additionally, Aureate Tradde serves as the exclusive distributor in India for sodium-ion cells manufactured by Jianghu Highstar Battery Technology.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Subscription StatusAs of 1:40 pm on 1 June
Retail Category0.91%
Non-Institutional Investors (NII)0.08 times
Qualified Institutional Buyers (QIB)0%

The SME IPO has received 18,40,000 shares, against the offered 37,02,000 shares on Monday, 1 June, 2026.

The shares of Aureate Tradde IPO are commanding a premium of ₹13 in the grey market, as per websites tracking the unlisted market. According to Investorgain, the GMP of Aureate Tradde IPO is +13, which means that the estimated listing price is likely to be ₹83, which is 18.57% higher than the IPO price of ₹70.

The IPO is a fixed-price offering aggregating approximately ₹27.29 crore, comprising solely of a fresh issue of 38.98 lakh equity shares. The company has set the issue price at ₹70 per share. The share allotment is likely to be completed on 3 June, while the company's shares are expected to debut on the BSE SME on 5 June. The net proceeds from the issue will be utilised towards funding working capital requirements of the company, repayment/pre-payment of certain borrowings, and meeting general corporate expenses.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Retail investors can bid for a minimum of 4,000 shares, translating into an investment of ₹2.8 lakh, while high-net-worth individuals (HNIs) must apply for at least 6,000 shares, requiring an investment of ₹4.2 lakh. Of the total issue, nearly 18.52 lakh shares have been earmarked for retail investors and 18.5 lakh shares for the non-institutional category. Corporate Makers Capital is managing the issue as the book-running lead manager, while MUFG Intime India has been appointed as the registrar. Giriraj Stock Broking will serve as the market maker for the IPO.

Investor Takeaway

Aureate Tradde's IPO has been subscribed over 50% on the second day of bidding.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.